Results 21 to 30 of about 8,639,868 (311)

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie   +4 more
wiley   +1 more source

Summary report of baseline study of employability related activities in Scottish colleges [PDF]

open access: yes, 2006
Providers report strong support for the development of employability skills and attributes,including core and 'soft' skills, both as discrete units and embedded within course provisionalongside other learning goals.
Kenneson, Summer   +2 more
core  

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

A scoping review of health co-benefit tests in the setting of a screening or health programme: Limited data to inform their potential use to address inequities

open access: yesSSM - Health Systems
Objective: The aim of this scoping review is to assess the extent, range and nature of health co-benefit tests and their application to address inequities in a screening or other health programme setting and to inform their potential use for a AAA ...
Tayla Schaapveld   +6 more
doaj   +1 more source

Evaluating the impact of Brexit on the pharmaceutical industry

open access: yesJournal of Pharmaceutical Policy and Practice, 2017
Introduction The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote.
Fawz Kazzazi   +5 more
doaj   +1 more source

Critical issues in implementing low vision care in the Asia-Pacific region

open access: yesIndian Journal of Ophthalmology, 2012
Two-thirds of the world′s population with low vision resides in the Asia-Pacific region. Provision of comprehensive low vision services is important to improve vision-related quality of life (QoL) for people with this condition.
Peggy Pei-Chia Chiang   +3 more
doaj   +1 more source

Pension Funding and the Economy: Would Proper Funding Cost Jobs? [PDF]

open access: yes, 2015
There is an ongoing debate in policy circles about the appropriate accounting standards for public sector pension funds. There are major differences between the standard practice of most pension funds and the policies that are advocated by many academic ...
Dean Baker, Nick Buffie
core  

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy